Sand Fly Saliva EnhancesLeishmania amazonensisInfection by Modulating Interleukin-10 Production
Open Access
- 1 March 2004
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (3) , 1240-1247
- https://doi.org/10.1128/iai.72.3.1240-1247.2004
Abstract
After transmission through the bite of female sand flies,Leishmaniaspp. can cause a broad spectrum of disease manifestations collectively known as leishmaniases.L. amazonensisis endemic in South America, where it causes cutaneous, diffuse cutaneous, and visceral leishmaniasis. In this study, we have provided evidence that salivary gland extracts (SGE) ofLutzomyia longipalpisenhancesL. amazonensisinfection. BALB/c mice infected intradermally in the ear with 105metacyclic promastigotes ofL. amazonensistogether with SGE (equivalent to 0.5 gland) showed an early onset of disease and larger lesions that contained ∼3-log-units more parasites than did controls. To determine the potential mechanism underlying this enhancement, we assessed cytokine production via reverse transcriptase PCR and enzyme-linked immunosorbent assay. Mice coinjected with parasites and SGE displayed higher levels of interleukin-10 (IL-10) mRNA in the ear tissues, as well as higher levels of IL-10 in supernatants of restimulated draining lymph node (LN) cells, than did controls. Flow cytometric analysis revealed high frequencies of IL-10-producing CD4+and CD8+T cells in the draining LN of mice coinjected with the parasite and SGE. In addition, we examined bone marrow derived-macrophage cultures and detected increased IL-10 but decreased nitric oxide (NO) production in cells exposed to SGE prior to infection withL. amazonensis. Together, these results imply that the sand fly saliva facilitatesLeishmaniaevasion of the host immune system by modulating IL-10 production.Keywords
This publication has 69 references indexed in Scilit:
- The TGF-? response toLeishmania chagasi in the absence of IL-12European Journal of Immunology, 2002
- Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as ImmunotherapyInfection and Immunity, 2002
- Skin-Derived Macrophages from Leishmania major-Susceptible Mice Exhibit Interleukin-12- and Interferon-γ-Independent Nitric Oxide Production and Parasite Killing After Treatment with Immunostimulatory DNAJournal of Investigative Dermatology, 2002
- High Intralesional Interleukin‐10 Messenger RNA Expression in Localized Cutaneous Leishmaniasis Is Associated with Unresponsiveness to TreatmentThe Journal of Infectious Diseases, 2001
- The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile CureThe Journal of Experimental Medicine, 2001
- Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis InfectionImmunity, 1996
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Interleukin‐10 Inhibits Antimicrobial Activity Against Leishmania major in Murine MacrophagesScandinavian Journal of Immunology, 1994
- Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape MechanismScience, 1992
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991